John T Seykora MD
Dermatopathology
Associate Professor, Dermatology, Perelman School of Medicine
Join to View Full Profile
421 Curie Blvd# 1011Philadelphia, PA 19104
Phone+1 215-662-2597
Fax+1 215-349-8339
Dr. Seykora is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Dermatopathology, 1997 - 1999- University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1993 - 1997
Weill Cornell MedicineClass of 1993
Certifications & Licensure
PA State Medical License 1994 - 2026
American Board of Pathology Anatomic Pathology- American Board of Pathology Dermatopathology
Publications & Presentations
PubMed
- LNS8801: An Enantiomerically Pure Agonist of the G Protein-Coupled Estrogen Receptor Suitable for Clinical Development.Christopher A Natale, Sophia Mercado, Richard Zhuang, Cristina Aguirre-Portolés, Israel Olayide
Cancer Research Communications. 2025-04-01 - Penn Academy for Skin Health (PASH): An Experiential Pipeline Program in Skin Biology and Dermatology for High-School Students.Elizabeth A Grice, Donna Brennan-Crispi, Natalia Rodriguez, David J Margolis, John T Seykora
The Journal of Investigative Dermatology. 2025-03-01 - Acetyl-CoA synthesis in the skin is a key determinant of systemic lipid homeostasis.Phuong T T Nguyen, Mia Shiue, Nina Kuprasertkul, Pedro Costa-Pinheiro, Luke T Izzo
Cell Reports. 2025-02-25
Press Mentions
- Risk Factors for Positive or Equivocal Margins After Wide Local Excision of 1345 Cutaneous MelanomasJuly 23rd, 2020
Study Reveals Possible Solution to Elevated Cancer Risk from Important Anti-Infection DrugNovember 5th, 2019
Safety and Biopsy Outcomes of a Topical Treatment (SM04554) for Male Androgenetic Alopecia (AGA): Results from a Phase 2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled TrialJune 1st, 2017
Grant Support
- Fibroblast dysregulation promotes dermal eosinophilic/Th2 inflammationUNIVERSITY OF PENNSYLVANIA2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
